Phase IIa, Evaluation of the Safety and Efficacy of WST11-mediated Vascular Targeted Photodynamic Therapy on Obstructing Endobronchial Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 May 2015
At a glance
- Drugs Padeliporfin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Steba Biotech
- 04 Jan 2012 Actual patient number is 3 according to ClinicalTrials.gov.
- 04 Jan 2012 Planned end date changed from 1 Oct 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.